Dermatophyte infections

  • A. Tosti
  • B. M. Piraccini


Tinea corporis is an infective skin disease resulting from invasion and proliferation by the causal fungi in the stratum corneum. The fungi most commonly involved are Microsporum canis, Tricophyton rubrum and Tricophyton mentagrophytes. It most commonly involves exposed parts of the body, but can affect any site. Typical lesions are annular in shape, with a raised scaling erythema-tous edge. The presence of perifollicular granulomatous papules (Majocchi’s granuloma) is a definite indication for systemic treatment.


Tinea Capitis Nail Plate Tinea Pedis Trichophyton Rubrum Tinea Corporis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Further reading

  1. Baran R, Feuilhade M, Datry A et al A randomized trial of amorolfine 5% solution nail lacquer combined with oral terbinafine compared with terbinafine alone in the treatment of dermatophyte toenail onychomycosis affecting the matrix region. Br J Dermatol 2001; 142: 1177–83.CrossRefGoogle Scholar
  2. Bennet ML, Fleischer AB, Loveless JW et al Oral griseofulvin remains the treatment of choice for tinea capitis in children. Pediatric Dermatol 2000; 17: 304–9.CrossRefGoogle Scholar
  3. Bräutigam M, Nolting S, Schpf RE et al Randomized double blind comparison terbinafine itraconazole for treatment of toenail tinea infection. Br Med J 1995; 311: 919–22.CrossRefGoogle Scholar
  4. Ceschin-Roques CG, Hänel H, Pruja-Bougaret SM et al Ciclopirox nail lacquer 8%: in vivo penetration into and through nails and in vitro effect on pig skin. Skin Pharmacol 1991; 4: 89–94.PubMedCrossRefGoogle Scholar
  5. De Doncker P, Decroix J, Piérard GE et al Antifungals pulse therapy for onychomycosis. Arch Dermatol 1996; 132: 34–41.PubMedCrossRefGoogle Scholar
  6. Elewski BE. Tina capitis: a current perspective. JAm Acad Dermatol 2000; 42: 1–20.CrossRefGoogle Scholar
  7. Gupta AK, Lynde CW, Konnikow N. Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis. J Am Acad Dermatol 2001; 44: 485–891.PubMedCrossRefGoogle Scholar
  8. Gupta AK, Shear NH. A risk-benefit assessment of the newer oral antifungal agents used to treat onychomycosis. Drug Safety 2000; 22: 33–52.PubMedCrossRefGoogle Scholar
  9. Katsambas A, Antoniou C, Frangouli E et al Itraconazole in the treatment of tinea corporis and tinea curtis. Clin Exp Dermatol 1993; 18: 322–5.PubMedCrossRefGoogle Scholar
  10. Montero JF. Fuconazole in the treatment of tinea capitis. Int J Dermatol 1998; 37: 870–3.CrossRefGoogle Scholar
  11. Savin RS. Treatment of chronic tinea pedis (athlete’s foot type) with topical terbinafine. J Am Acad Dermatol 1990; 23: 786–9.PubMedCrossRefGoogle Scholar
  12. Svejgaard EL. Recalcitrant dermatophyte infection. Dermatol Ther 1997; 3: 79–83.Google Scholar
  13. Tosti A, Piraccini BM. Treatment of onychomycosis: a European Experience. Dermatol Ther 1997; 3: 79–83.Google Scholar
  14. Tosti A, Piraccini BM, Stinchi C et al Relapses of onychomycosis after successful treatment with systemic antifungals: a three year follow-up. Dermatology 1998; 197: 162–6.PubMedCrossRefGoogle Scholar
  15. Tosti A, Piraccini BM, Stinchi C et al Treatment of dermatophyte nail infections: an open randomized study comparing intermittent terbinafine therapy with continuous terbinafine treatment and intermittent itraconazole therapy. J Am Acad Dermatol 1996; 34: 595–600.PubMedCrossRefGoogle Scholar
  16. Zaias N. Onychomycosis. Arch Dermatol 1972; 105: 263–74.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2003

Authors and Affiliations

  • A. Tosti
  • B. M. Piraccini

There are no affiliations available

Personalised recommendations